A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Celebrex Patient, Information, Instructions - Celecoxib
Celebrex Patient, Information, Instructions - Celecoxib
PATIENT INFORMATION
CELEBREX can cause discomfort
and rarely, more serious
side effects, such as gastrointestinal
bleeding, which may
result in hospitalization and even fatal
outcomes. Although serious GI
tract ulcerations and
bleeding can occur without warning symptoms, patients should be
alert for the signs and symptoms of ulcerations and bleeding,
and should ask for medical
advice when observing any indicative signs or symptoms. Patients
should be apprised of the importance of this follow-up
(see WARNINGS, Risk of Gastrointestinal
Ulceration, Bleeding and Perforation).
Patients should promptly report
signs or symptoms of gastrointestinal ulceration or bleeding,
skin rash,
unexplained weight gain,
or edema to their physicians.
Patients should be informed of the warning signs and symptoms of
hepatotoxicity (e.g., nausea,
fatigue, lethargy, pruritus,
jaundice, right
upper quadrant tenderness, and "flu-like" symptoms). If
these occur, patients should be instructed to stop therapy
and seek immediate
medical therapy.
Patients should also be instructed to seek immediate
emergency help in
the case of an anaphylactoid
reaction (see WARNINGS).
In late pregnancy
CELEBREX should be avoided because it may cause
premature closure of the ductus
arteriosus.
top
